LYKA LABS
Back to Income Statement
|
LYKA LABS Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹111 Cr | ₹93 Cr | ₹194 Cr | ₹86 Cr | ₹61 Cr |
What is the latest Revenue of LYKA LABS ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹111 Cr |
| Mar2024 | ₹93 Cr |
| Mar2023 | ₹194 Cr |
| Mar2022 | ₹86 Cr |
| Mar2021 | ₹61 Cr |
How is Revenue of LYKA LABS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹111 Cr | 19.47 | |
| Mar2024 | ₹93 Cr | -52.05 | |
| Mar2023 | ₹194 Cr | 125.02 | |
| Mar2022 | ₹86 Cr | 40.27 | |
| Mar2021 | ₹61 Cr | - | |
Compare Revenue of peers of LYKA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LYKA LABS | ₹178.4 Cr | -3.2% | -24.4% | -46.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,407.0 Cr | -2.2% | 2.5% | 1.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,596.0 Cr | -1.2% | -4.5% | 5.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,619.0 Cr | -2.1% | -0.2% | 36.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,544.0 Cr | -2.4% | -2.1% | 11.5% | Stock Analytics | |
| CIPLA | ₹98,767.6 Cr | -4.6% | -8% | -16.8% | Stock Analytics | |
LYKA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LYKA LABS | -3.2% |
-24.4% |
-46.2% |
| SENSEX | -3.7% |
-13.2% |
-2% |
You may also like the below Video Courses